Clinical characteristics of the B-CLL patient material at testing time
Characteristic . | Patients, % . |
|---|---|
| Sex | |
| Male | 68 |
| Female | 32 |
| Age, y | |
| 50-59 | 15 |
| 60-69 | 46 |
| 70-79 | 36 |
| 80-89 | 3 |
| Rai stage | |
| 0 | 24 |
| I | 30 |
| II | 13 |
| III | 16 |
| IV | 17 |
| Treatment | |
| Previously untreated | 32 |
| Previously treated* | 68 |
Characteristic . | Patients, % . |
|---|---|
| Sex | |
| Male | 68 |
| Female | 32 |
| Age, y | |
| 50-59 | 15 |
| 60-69 | 46 |
| 70-79 | 36 |
| 80-89 | 3 |
| Rai stage | |
| 0 | 24 |
| I | 30 |
| II | 13 |
| III | 16 |
| IV | 17 |
| Treatment | |
| Previously untreated | 32 |
| Previously treated* | 68 |
n = 75 patients with B-CLL.
Most patients received chlorambucil or fludarabine therapy. At least 1 month elapsed since the last treatment.